Clinical Trials

Myasthenia Gravis, Thymoma

NCT06838910 2025-12-01

Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma

20 enrolled

Thymoma

NCT03694002 2025-10-30

Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery

21 enrolled 17 charts

Thymoma

NCT06790706 2025-10-06

IMMUNORARE5

EndocrineGastrointestinalGynecologicHead & NeckNETThoracic

154 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Thymoma, Gestational Trophoblastic Disease, Thyroid Carcinoma, Anaplastic

NCT07181720 2025-10-02

CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors

Phase 1 Recruiting

90 enrolled

EndocrineGenitourinaryGynecologicHead & NeckThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thymoma, Thyroid Carcinoma, Anaplastic

NCT05104736 2025-09-19

PT-112 in Subjects With Thymoma and Thymic Carcinoma

53 enrolled

Thymic epithelial tumor, Peripheral Nervous System Diseases, Thymoma, Thymus Neoplasms

NCT07179341 2025-09-17

Survival Nomogram for Patients With Thymic Carcinoma

Phase NA Completed

156 enrolled

Thymoma

NCT05461430 2025-09-15

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

200 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT03463460 2025-08-24

Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer

30 enrolled

Thymoma

NCT06186726 2025-06-13

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

48 enrolled

Thymoma

NCT05667948 2025-05-22

Molecular Analysis and Treatment Options of Thymic Malignancies

500 enrolled

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT05255965 2025-01-16

IL-8+ naïve T Cells as a Biomarker for Thymoma Identification

Completed

310 enrolled

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Thymoma

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Withdrawn

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT06692062 2024-11-18

Hypofractionated Radiotherapy for Thymic Epithelial Tumors

Phase NA Recruiting

100 enrolled

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT01306045 2024-10-01

Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies

647 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Thymoma, Small Cell Lung Carcinoma

NCT01621568 2024-09-24

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

56 enrolled 15 charts

Thymoma, Thymus Neoplasms

NCT05214612 2024-07-31

Predictors and Prognostic Factors of Myasthenia Gravis Outcome

30 enrolled

BreastGastrointestinalLymphoidSarcomaThoracic

Myasthenia Gravis, Nervous System Diseases, Thymoma, Thymus Hyperplasia, Autoimmune Diseases of the Nervous System, Neuromuscular Junction Diseases

NCT04072393 2024-07-12

Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers

Phase NA Terminated

24 enrolled

Breast Neoplasms, Esophageal Neoplasms, Hodgkin Disease, Lung Neoplasms, Lymphoma, Non-Hodgkin, Sarcoma, Thymoma

NCT04321330 2024-06-11

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

34 enrolled

Phase NA Active not recruiting

Thymoma

NCT05682742 2024-06-03

Clinical Investigation of the da Vinci Surgical System

53 enrolled

GenitourinaryOtherThoracic

Genital Diseases, Female, Hernia, Inguinal, Hernia, Ventral, Mediastinal Neoplasms, Obesity, Morbid, Prostatic Diseases, Prostatic Neoplasms, Thymoma, Pelvic Organ Prolapse

NCT03921671 2024-05-29

RELEVENT

Phase 2 Unknown

60 enrolled

Neoplasm Metastasis, Thymoma

NCT06402708 2024-05-10

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

Phase 3 Recruiting

172 enrolled

Thymoma

NCT04925947 2024-04-16

A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors

Phase 2 Terminated

4 enrolled 10 charts

Thymoma

NCT06301945 2024-03-27

INTHYM

1,020 enrolled

Thymic epithelial tumor, Thymoma

NCT04469725 2024-03-12

KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma

Phase 2 Terminated

95 enrolled

Thymoma

NCT02633553 2023-12-08

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Phase NA Recruiting

238 enrolled

EndocrineNETOther solid neoplasmThoracic

Thymoma

NCT04375267 2023-11-14

LuPARP

Phase 1 Unknown

18 enrolled

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT05455840 2023-10-31

A Prospective, Single-Center Investigation of the da Vinci SP® Surgical System in Anterior Mediastinal Disease

Phase NA Unknown

15 enrolled

Myasthenia Gravis, Thymoma

NCT04662645 2023-10-26

Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers

Phase NA Completed

68 enrolled

Lung Neoplasms, Thymoma

NCT05832827 2023-10-23

Artemis

35 enrolled

Phase EARLY_PHASE1 Unknown

Thymoma

NCT06086327 2023-10-17

Application of 68Ga-Pentixafor PET/CT for Thymoma

100 enrolled

Other solid neoplasmThoracic

Thymoma

NCT06010277 2023-08-24

FLEX

Phase 4 Unknown

50 enrolled

Mesothelioma, Thymoma

NCT00010257 2023-06-29

Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma

46 enrolled 7 charts

Thymoma

NCT00003283 2023-06-15

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

38 enrolled

Phase 2 Not yet recruiting

Thymoma

NCT05816694 2023-04-18

The Efficacy and Safety of Nanoparticle Albumin-bound (NAB)-Paclitaxel Plus Cisolation Versus CEP (Cisplatin, Epirubicin,Cyclophosphamide) in Induction Therapy for Thymoma: a Study for a Single-center Prospective Phase II Randomized Controlled Train.

50 enrolled

Thymoma

NCT03193437 2023-02-16

SELECT

Phase 2 Terminated

8 enrolled 11 charts